Joseph V Gulfo Selected Research

Neoplasms (Cancer)

6/2004	Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer.
5/2004	Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
4/2004	Immunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules.
10/2003	Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph V Gulfo Research Topics

Disease

4	Neoplasms (Cancer) 06/2004 - 10/2003
1	Breast Neoplasms (Breast Cancer) 06/2004

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 06/2004 - 10/2003
3	EpitopesIBA 06/2004 - 04/2004
3	AntigensIBA 06/2004 - 04/2004
2	Peptides (Polypeptides)IBA 06/2004 - 05/2004
2	Histocompatibility Antigens Class IIIBA 05/2004 - 04/2004
1	Protein Subunit VaccinesIBA 06/2004
1	invariant chain (Ii-Key)IBA 06/2004
1	Histocompatibility Antigens Class IIBA 05/2004
1	HLA-DR Antigens (HLA-DR)IBA 05/2004
1	Pharmaceutical PreparationsIBA 04/2004
1	Interleukin-2 (IL2)IBA 10/2003
1	MHC class II transactivator proteinIBA 10/2003

Therapy/Procedure

2	Immunotherapy 04/2004 - 10/2003
1	Therapeutics 04/2004
1	Injections 10/2003